Synaptogenix Inc (SNPX)

[rayovacAAA]

"POST HOC ANALYSIS - WHAT IS IT?"




https://senguptasresearchacademy.com/post-hoc-analysis/

Though it may be ok to explore such analysis in order to salvage a negative result from a clinical trial, purists consider this not as robust as the outcome that the trial was designed for. In other words, even if we get a significant outcome in post hoc analysis, it should be taken with a pinch of salt and the conclusions not be relied upon too much. Even the US FDA does not consider post hoc analysis while granting FDA approval for drugs and devices which show clinical efficacy based on post hoc analysis alone.